{
  "compound": "Cannabinoids (THC, CBD, synthetic)",
  "condition": "ALZHEIMERS",
  "effect_size": "N/A (mechanistic)",
  "study_type": "MECHANISTIC",
  "source": "NORML:ALZHEIMERS_MECHANISTIC_001",
  "participants": "Mechanistic review with preclinical data",
  "year": 2016,
  "notes": "Cannabinoids and Neuroinflammation in Alzheimer's Disease",
  "confidence": "medium",
  "abstract": "THC reduces A\u03b2 aggregation; CBD reduces neuroinflammation; CB2 activation clears plaques; ECS dysregulated in AD brains"
}